Back to top
more

Abbott Laboratories (ABT)

(Real Time Quote from BATS)

$117.15 USD

117.15
4,982,512

-0.98 (-0.83%)

Updated Sep 18, 2024 09:36 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Ecolab (ECL) to Report Q3 Earnings: What's in the Offing?

Ecolab's (ECL) Global Industrial segment is likely to have gained from the Water, Food & Beverage and Life Sciences sub-units in Q3.

Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates

Abbott (ABT) delivered earnings and revenue surprises of 8.89% and 4.67%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Abbott (ABT) Might Surprise This Earnings Season

Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Align Technology (ALGN) to Post Q3 Earnings: What's in Store?

Align Technology (ALGN) is expected to have gained from gradual recovery in Clear Aligner shipment volumes in Q3.

Calix (CALX) to Report Q3 Earnings: What's in the Cards?

Backed by a robust balance sheet, Calix's (CALX) third-quarter earnings are likely to have been driven by technological innovations for upgraded products.

The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System

The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System

Intuitive Surgical (ISRG) Q3 Earnings Top Estimates, Down Y/Y

Intuitive Surgical's (ISRG) third-quarter results reflect improvement in procedure volume.

Walgreens Boots (WBA) Q4 Earnings Top Estimates, Margins Down

Walgreens Boots' (WBA) fiscal fourth-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.

COVID-19 Antigen Test Launch to Drive Abbott (ABT) Q3 Earnings

Abbott (ABT) is expected to register strong sales in the Adult Nutrition category, banking on growing global demand for its nutrition brand Ensure.

Nalak Das headshot

An Investment Strategy for Q3 Earnings in a Volatile Market

Investment in low-beats stocks with a favorable Zacks Rank and positive Earnings ESP will be a sound strategy to enhance one's portfolio.

Abbott (ABT) Stock Moves -0.57%: What You Should Know

In the latest trading session, Abbott (ABT) closed at $107.75, marking a -0.57% move from the previous day.

Boston Scientific Gets a Boost From MedSurg Arm Amid Coronavirus

Within Endoscopy, Boston Scientific (BSX) believes that business recovery started since June.

Abbott (ABT) Earnings Expected to Grow: Should You Buy?

Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Edwards Lifesciences' (EW) Q3 Earnings?

Robust customer adoption of the TruWave disposable pressure monitoring devices and the INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q3 revenues.

Why Abbott (ABT) is Poised to Beat Earnings Estimates Again

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle

The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle

Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands

Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.

Here's Why Momentum Investors Will Love Abbott (ABT)

Does Abbott (ABT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Abbott (ABT) Upgraded to Buy: Here's What You Should Know

Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?

Is (ABT) Outperforming Other Medical Stocks This Year?

Abbott's Data From Interim Clinical Study of ID NOW Positive

Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.

Sheraz Mian headshot

Top Research Reports for Visa, Walmart & Abbott

Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Walmart (WMT) and Abbott Laboratories (ABT).

Sriparna Ghosal headshot

3 Large-Cap MedTech Growth Stocks to Buy Amid the Pandemic

Let's take a look at three large-cap MedTech stocks that are currently flourishing on the back of a number of positive developments.

Urmimala Biswas headshot

Coronavirus Drives Testing Stocks: Is There Room for More Upside?

Given the current testing requirements across the world, the diagnostic testing business for COVID-19 is rapidly evolving.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed the most recent trading day at $108.56, moving +1.93% from the previous trading session.